Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

Translated title of the contribution: Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

M. Cudkowicz, L.H. van den Berg, J.M. Shefner, H. Mitsumoto, J.S. Mora, A. Ludolph, O. Hardiman, M.E. Bozik, E.W. Ingersoll, D. Archibald, A.L. Meyers, Y. Dong, W.R. Farwell, X et al, D. Kerr

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionDexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Original languageUndefined/Unknown
Pages (from-to)1059-1067
Number of pages9
JournalLancet Neurology
Volume12
Issue number11
Publication statusPublished - 2013

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde (GENK)
  • Geneeskunde(GENK)
  • Medical sciences
  • Bescherming en bevordering van de menselijke gezondheid

Cite this